Altre lingue Talis Biomedical Corporation

Azioni

TLIS

US87424L2079

Mercato chiuso - Nasdaq Altri mercati azionari 22:30:00 26/04/2024			Variaz. 5gg	Var. 1 gen.
9,14 ^USD	+1,56%		+2,70%	+22,68%

28/03	Talis Biomedical Corporation riporta i risultati degli utili per l'intero anno terminato il 31 dicembre 2023	CI
2023	Talis Biomedical Corporation riporta i risultati degli utili per il terzo trimestre e i nove mesi conclusi il 30 settembre 2023	CI

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

North American Morning Briefing : Stocks Seen -2-	02/04
Talis Biomedical Corporation Reports Earnings Results for the Full Year Ended December 31, 2023	28/03
North American Morning Briefing : Stock Futures Muted; Nvidia Slips in Offhours Trading	22/11
Talis: Q3 Earnings Snapshot	14/11
Talis Biomedical Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	14/11
Talis Biomedical Announces Exploration of Strategic Alternatives and Cost Reduction Plan to Preserve Cash	14/11
Talis Biomedical Announces Exploration of Strategic Alternatives	14/11
Talis Biomedical Corporation Announces Resignation of Melissa Gilliam from its Board of Directors, as Member of Nominating and Corporate Governance Committee and as Member and Co-Chairperson of Science, Technology and Clinical Affairs Committee	01/09/23
Talis: Q2 Earnings Snapshot	10/08/23
Talis Biomedical Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	10/08/23
Talis Biomedical Announces Second Quarter 2023 Financial Results and Business Update	10/08/23
Talis Biomedical to Report Second Quarter 2023 Financial Results and Provide a Business Update on August 10, 2023	03/08/23
Talis Biomedical Corporation Announces Resignation of Andrew A. Lukowiak as President and Chief Scientific Officer	02/08/23
Talis Biomedical Announces Andrew Lukowiak, Ph.D., as President and Chief Scientific Officer (CSO)	02/08/23
New Data Presented at the Infectious Disease Society for Obstetrics and Gynecology (IDSOG) Annual Meeting Differentiate Talis Biomedical’s Women’s and Sexual Health Product Menu	27/07/23
Talis Biomedical Corporation Announces New Data Supporting the Development of Its Planned CT/NG/TV and Vinal Infections Panels	27/07/23
Talis Biomedical Regains Compliance with Nasdaq Minimum Bid Price Requirement	24/07/23
Talis Biomedical Announces 1-for-15 Reverse Stock Split	05/07/23
TALIS ALERT: Bragar Eagel & Squire, P.C. is Investigating Talis Biomedical Corporation on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm	22/06/23
TALIS BIOMEDICAL CORP : Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)	23/05/23

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Talis Biomedical Corporation

Azioni

TLIS

US87424L2079

Altre lingue

Filtri